Results
|
1.
|
Report from the 2018 consensus conference on immunomodulating agents in thoracic transplantation: Access, formulations, generics, therapeutic drug monitoring, and special populations. MedStar authors:
Year: 2020
Citation: - Journal of Heart & Lung Transplantation. 39(10):1050-1069, 2020 10.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Baran D, Claridge T, Cochrane AB, Colvin M, Dawson K, Dipchand A, Doligalski C, Ensor CR, Flattery M, Ford K, Girgis R, Ivulich S, Jennings D, Khuu T, Kittleson M, Lindenfeld J, Lyster H, Miller T, Page RL 2nd, Peters L, Russell S, Scheel J, Schweiger M, Shullo M, Simpson K, Stuckey L, Tse T, Uber P, Weeks P, Weill D, Yost C
|
|
2.
|
U.S. drug shortages for medications used in adult critical care (2001-2016). MedStar authors:
- Goyal, Munish
- Hawley, Kristy L
- Mazer-Amirshahi, Maryann
- Umar, Suleman A
Year: 2017
Citation: - Journal of Critical Care. 41:283-288, 2017 Jun 09
Institution:
- MedStar Union Memorial Hospital
- MedStar Washington Hospital Center
Department:
- Emergency Medicine
- Medicine/Pulmonary Critical Care
- Surgery
Medline publication type:
All authors: - Fox ER, Goyal M, Hawley KL, Mazer-Amirshahi M, Pines JM, Umar SA, Zocchi M
|
|
3.
|
Drug shortages: Implications for medical toxicology. MedStar authors:
Citation: - Clinical Toxicology: The Official Journal of the American Academy of Clinical Toxicology & European Association of Poisons Centres & Clinical Toxicologists. 53(6):519-24, 2015 Jul.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Fox E, Hawley KL, Mazer-Amirshahi M, Nelson LS, Pines JM, Zocchi M
|
|
4.
|
International Expert Consensus on Switching Platelet P2Y<sub>12</sub> Receptor-Inhibiting Therapies. MedStar authors:
Year: 2017
Citation: - Circulation. 136(20):1955-1975, 2017 Nov 14
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Alexopoulos D, Angiolillo DJ, Aradi D, Bhatt DL, Bonello L, Cuisset T, De Luca L, Franchi F, Gurbel PA, Hochholzer W, James S, Mehran R, Montalescot G, Price MJ, Rollini F, Schneider DJ, Sibbing D, So DYF, Storey RF, Tantry US, Trenk D, Valgimigli M, Waksman R, Wang TY
|
|
5.
|
ACMT Position Statement on Prescription Drug Shortages. [Review] MedStar authors:
Year: 2020
Citation: - Journal of Medical Toxicology: Official Journal of the American College of Medical Toxicology. 16(3):349-351, 2020 07.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Fox ER, Mazer-Amirshahi M, Nelson LS, Smith SW, Stolbach AI
|
|
6.
|
|
|
7.
|
|
|
8.
|
The impact of in-hospital P2Y12 inhibitor switch in patients with acute coronary syndrome. MedStar authors:
- Ben-Dor, Itsik
- Buchanan, Kyle
- Gajanana, Deepakraj
- Iantorno, Micaela
- Kolm, Paul
- Okubagzi, Petros
- Pichard, Augusto D
- Rogers, Toby
- Satler, Lowell F
- Thourani, Vinod H
- Torguson, Rebecca
- Waksman, Ron
- Weintraub, William S
Year: 2018
Citation: - Cardiovascular Revascularization Medicine. 19(8):912-916, 2018 12.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Ben-Dor I, Buchanan KD, Gajanana D, Iantorno M, Kolm P, Okubagzi PG, Pichard AD, Rogers T, Satler LF, Thourani VH, Torguson R, Waksman R, Weintraub WS
|
|
9.
|
Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro. [] MedStar authors:
Year: 2014
Citation: - Diabetes Care. 37(8):2317-25, 2014 Aug.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Ahren B, Chow FC, Fonseca VA, Gross JL, Harmony 6 Study Group, Johnson SL, Leiter LA, Miller D, Ratner RE, Rosenstock J, Stewart MW, Yang F
|
|
10.
|
Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial. MedStar authors:
Year: 2019
Citation: - Diabetes Care. 42(11):2108-2116, 2019 11.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Blonde L, Del Prato S, Frias J, Henry R, Ji C, Niemoeller E, Rosenstock J, Shehadeh N, Souhami E
|